Best GLP-1 Options Without Insurance: Compounded & Savings Programs

Finding affordable GLP-1 medications without insurance can feel overwhelming, but several legitimate options exist that make these powerful weight loss treatments accessible. The most cost-effective approaches include compounded versions from licensed pharmacies and manufacturer savings programs, with monthly costs ranging from $149 to $1,000 depending on your choice of provider and medication.

This comparison examines the top platforms offering GLP-1 medications to uninsured patients, focusing on pricing transparency, medication quality, physician oversight, and overall patient experience. We analyzed current pricing data, reviewed clinical protocols, and evaluated patient feedback to help you make an informed decision about your weight loss process.

Ro (Roman): What You Get

Ro has positioned itself as one of the more affordable telehealth platforms for GLP-1 medications, with compounded semaglutide starting at $145 per month and tirzepatide at $295 monthly. The platform operates through a streamlined online consultation process where patients complete a comprehensive health questionnaire reviewed by licensed physicians.

The medication selection includes compounded semaglutide and tirzepatide, sourced from FDA-registered 503B compounding pharmacies. Ro's semaglutide formulation comes in pre-filled syringes with doses ranging from 0.25mg to 2.4mg weekly, following the standard escalation protocol used in clinical trials. Their tirzepatide offering mirrors the Mounjaro dosing schedule, starting at 2.5mg and escalating to 15mg based on patient response and tolerance.

The consultation process takes approximately 15-20 minutes and includes questions about medical history, current medications, weight loss goals, and previous diet attempts. Ro's medical team reviews applications within 24-48 hours, and approved patients receive their medication via temperature-controlled shipping within 7-10 business days. The platform provides injection training videos and ongoing support through their patient portal.

Ro offers a subscription model with automatic refills, though patients can pause or cancel at any time. The platform accepts HSA/FSA payments and provides detailed receipts for potential insurance reimbursement. Their customer service operates Monday through Friday with extended hours, and patients can message their care team through the app.

Pros:

• Competitive pricing for semaglutide at $145/month
• Both semaglutide and tirzepatide available
• Quick online consultation process
• HSA/FSA accepted
• Comprehensive injection training resources

Cons:

• No live physician consultations
• Limited ongoing medical monitoring
• Tirzepatide pricing higher than competitors
• Longer shipping times compared to some platforms

Hims & Hers: What You Get

Hims & Hers entered the GLP-1 market with a focus on accessibility and brand recognition, offering compounded semaglutide starting at $199 per month. The platform leverages its established telehealth infrastructure to provide weight loss medications alongside their existing hair loss, sexual health, and skincare treatments.

Currently, Hims & Hers primarily offers compounded semaglutide through their weight loss program, with plans to expand to additional GLP-1 medications. Their semaglutide comes in pre-filled syringes with standard dosing that begins at 0.25mg weekly and can escalate to 2.4mg based on physician recommendations and patient tolerance. The medication is compounded at FDA-registered facilities following USP standards.

The consultation process involves an online assessment that takes 10-15 minutes, covering medical history, weight loss attempts, current health status, and treatment goals. Licensed physicians review applications and may request additional information or recommend alternative treatments based on individual health profiles. Approved patients typically receive their medication within 3-5 business days via expedited shipping.

Hims & Hers provides a mobile app for tracking progress, scheduling refills, and communicating with care teams. The platform offers monthly check-ins through their messaging system and provides educational resources about proper injection techniques, side effect management, and lifestyle modifications that enhance GLP-1 effectiveness. Their subscription model includes automatic refills with the flexibility to adjust timing or pause treatment.

The platform accepts various payment methods including HSA/FSA accounts and offers financing options for qualified patients. Customer support is available seven days a week through multiple channels including phone, chat, and email. Hims & Hers also provides a satisfaction guarantee with refunds available for patients who experience significant adverse effects within the first month.

Pros:

• Fast shipping (3-5 business days)
• Established telehealth platform with good reputation
• Comprehensive mobile app experience
• Seven-day customer support
• Satisfaction guarantee available

Cons:

• Higher starting price at $199/month
• Limited to semaglutide only
• Less physician interaction compared to traditional care
• Newer to the weight loss medication space

Price Comparison: Ro vs Hims & Hers

The pricing difference between Ro and Hims & Hers becomes significant over time, with Ro offering semaglutide at $145 monthly compared to Hims & Hers' $199 starting price. Over a six-month treatment period, this represents a $324 difference, and over a full year, patients save $648 by choosing Ro's semaglutide option.

However, pricing analysis must consider the total value proposition. Hims & Hers justifies their higher pricing through faster shipping, more comprehensive customer support, and their satisfaction guarantee program. Ro's lower pricing reflects their streamlined operational model but may result in longer wait times and less personalized support.

Both platforms accept HSA/FSA payments, which can provide significant tax advantages for eligible patients. Neither platform currently accepts traditional insurance, but both provide detailed receipts that patients can submit for potential reimbursement depending on their insurance policy's coverage for weight loss treatments.

For patients considering tirzepatide, Ro offers this newer medication at $295 monthly, while Hims & Hers has not yet added tirzepatide to their formulary. This gives Ro a significant advantage for patients who may benefit from tirzepatide's dual-action mechanism, which has shown superior weight loss results in clinical trials compared to semaglutide alone.

Medication Options: Ro vs Hims & Hers

Ro provides a more comprehensive medication selection with both semaglutide and tirzepatide available through their platform. Their semaglutide formulation follows the standard clinical protocol established in the STEP trials, starting at 0.25mg weekly and escalating every four weeks to 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg based on patient tolerance and weight loss response.

The tirzepatide option from Ro follows the dosing schedule validated in the SURMOUNT clinical trials, beginning at 2.5mg weekly and potentially escalating to 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. This dual GIP/GLP-1 receptor agonist has demonstrated superior weight loss outcomes compared to semaglutide in head-to-head studies, with patients achieving an average of 22.5% body weight reduction compared to 16.9% with semaglutide.

Hims & Hers currently focuses exclusively on compounded semaglutide, which may limit options for patients who don't respond optimally to this medication or experience significant side effects. However, their semaglutide formulation is well-established and has extensive clinical data supporting its safety and efficacy for weight management.

Both platforms source their compounded medications from FDA-registered 503B pharmacies that follow current Good Manufacturing Practices (cGMP). These compounded versions contain the same active ingredient as brand-name medications like Ozempic and Wegovy but are prepared in smaller batches and may have different inactive ingredients or delivery mechanisms.

The quality assurance protocols differ between platforms, with Ro providing detailed certificates of analysis for their compounded medications and Hims & Hers offering batch testing information through their patient portal. Both platforms ensure proper cold-chain storage and shipping to maintain medication stability and potency.

Doctor Quality and Oversight

The level of physician oversight represents a crucial difference between these platforms and traditional medical care. Ro employs licensed physicians across multiple states who review patient applications and make prescribing decisions based on submitted health information. However, the consultation process is primarily asynchronous, with limited opportunities for real-time discussion about treatment concerns or side effects.

Hims & Hers utilizes a network of board-certified physicians who specialize in telehealth consultations. Their medical team includes endocrinologists and internal medicine specialists with experience in weight management, though patients typically interact with nurse practitioners for routine follow-ups rather than the prescribing physician.

Both platforms require patients to have a BMI of 27 or higher with weight-related comorbidities, or a BMI of 30 or higher, aligning with FDA-approved indications for GLP-1 medications. The initial screening process excludes patients with certain medical conditions including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Ongoing monitoring varies significantly between platforms. Ro provides quarterly check-ins through their patient portal and encourages patients to report side effects or concerns through their messaging system. Hims & Hers offers more frequent touchpoints with monthly progress assessments and proactive outreach for patients experiencing common side effects like nausea or constipation.

Neither platform provides the comprehensive monitoring available through traditional endocrinology practices, which might include regular lab work, body composition analysis, or in-person physical examinations. Patients with complex medical histories or those requiring intensive monitoring may benefit more from conventional medical care or platforms offering more robust physician interaction, such as FormBlends' physician-supervised approach.

Patient Experience and Reviews

Patient satisfaction data reveals important differences in user experience between these platforms. Ro maintains an average rating of 4.2 out of 5 stars across major review platforms, with patients frequently praising the affordable pricing and straightforward ordering process. Common complaints include longer shipping times and difficulty reaching customer service during peak periods.

Hims & Hers scores slightly higher with a 4.4 out of 5 average rating, with patients highlighting the fast delivery times and responsive customer support. However, some users express frustration with the higher pricing and limited medication options compared to competitors offering tirzepatide.

Clinical outcomes appear comparable between platforms, with both reporting average weight loss of 12-15% of body weight over six months for patients who complete their programs. These results align with published clinical trial data for semaglutide, though individual results vary significantly based on adherence, lifestyle modifications, and baseline characteristics.

Side effect management represents an area where patient experiences diverge. Ro patients report receiving standard educational materials about common GLP-1 side effects but limited personalized guidance for managing issues like nausea, constipation, or injection site reactions. Hims & Hers provides more proactive side effect management through their nursing team, with patients receiving personalized recommendations for dietary modifications and symptom relief strategies.

Prescription fulfillment reliability shows Ro achieving approximately 94% on-time delivery rates, while Hims & Hers maintains 97% on-time delivery due to their expedited shipping protocols. Both platforms have experienced occasional supply chain disruptions affecting compounded medications, though these issues typically resolve within 1-2 weeks.

Which Is Right for You?

Choose Ro if you prioritize affordability and need access to both semaglutide and tirzepatide options. Their platform works best for patients comfortable with minimal physician interaction who can self-manage minor side effects and prefer to save money on monthly medication costs. Ro is particularly suitable for patients who have previously used GLP-1 medications and understand the treatment protocol.

Select Hims & Hers if you value fast delivery, responsive customer support, and don't mind paying a premium for enhanced service. This platform suits patients new to GLP-1 medications who may benefit from more frequent check-ins and proactive support during the initial treatment phase. The satisfaction guarantee also provides peace of mind for first-time users.

Consider FormBlends if you prefer comprehensive physician oversight with personalized treatment planning. Our physician-supervised approach includes live consultations, customized dosing protocols, and ongoing monitoring that bridges the gap between telehealth convenience and traditional medical care. We offer competitive pricing on compounded semaglutide, tirzepatide, and liraglutide with the added benefit of direct physician access throughout your treatment plan.

Patients with complex medical histories, multiple medications, or previous adverse reactions to weight loss treatments may benefit most from platforms offering enhanced medical supervision rather than automated prescription services. The choice ultimately depends on your individual medical needs, budget constraints, and preference for physician interaction.

Frequently Asked Questions

How much do GLP-1 medications cost without insurance?

GLP-1 medications without insurance typically cost $145-$1,000 per month depending on whether you choose compounded versions through telehealth platforms or brand-name medications from traditional pharmacies. Compounded semaglutide averages $145-$199 monthly, while brand-name Ozempic or Wegovy can cost $800-$1,000 without insurance coverage.

Are compounded GLP-1 medications as effective as brand-name versions?

Compounded GLP-1 medications contain the same active ingredients as brand-name versions and show similar clinical effectiveness when prepared by FDA-registered pharmacies following proper protocols. However, compounded medications may have different inactive ingredients and haven't undergone the same extensive clinical trials as FDA-approved brand-name drugs.

What's the difference between semaglutide and tirzepatide for weight loss?

Tirzepatide typically produces greater weight loss than semaglutide due to its dual-action mechanism targeting both GLP-1 and GIP receptors. Clinical trials show average weight loss of 22.5% with tirzepatide compared to 16.9% with semaglutide, though tirzepatide costs more and may cause different side effects.

Do I need a prescription for compounded GLP-1 medications?

Yes, all GLP-1 medications require a valid prescription from a licensed physician, including compounded versions. Telehealth platforms provide online consultations with licensed doctors who evaluate your eligibility and write prescriptions for appropriate candidates.

How long does it take to see weight loss results with GLP-1 medications?

Most patients begin seeing weight loss within 2-4 weeks of starting GLP-1 medications, with significant results typically appearing after 12-16 weeks of consistent use. Maximum weight loss usually occurs after 6-12 months of treatment combined with appropriate lifestyle modifications.

Ready to Start Your Weight Loss Goals?

Choosing the right GLP-1 medication provider requires careful consideration of your medical needs, budget, and preferences for physician interaction. While both Ro and Hims & Hers offer legitimate pathways to affordable GLP-1 medications, the level of medical oversight and personalized care varies significantly between platforms.

At FormBlends, we bridge the gap between telehealth convenience and comprehensive medical care through our physician-supervised approach. Our licensed physicians conduct live consultations, develop personalized treatment plans, and provide ongoing monitoring throughout your weight loss process. We offer competitive pricing on compounded semaglutide, tirzepatide, and liraglutide while maintaining the highest standards for clinical research and quality data.

Ready to explore your options with personalized physician guidance? Take our free physician assessment to determine which GLP-1 medication might be right for your unique situation. Our medical team will review your health history, discuss your weight loss goals, and recommend the most appropriate treatment approach based on current clinical evidence.

Sources

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002.

2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216.

3. Ro Body Program pricing and medication information. Accessed March 13, 2026. Available at: https://ro.co/weight-loss/

4. Hims & Hers Weight Loss Program details. Accessed March 13, 2026. Available at: https://www.hims.com/weight-loss

5. FDA. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. Updated February 2026.

6. American Association of Clinical Endocrinologists. Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity. Endocrine Practice. 2024;30(2):138-169.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The information provided should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any weight loss medication or treatment program. Individual results may vary, and no medication or treatment is guaranteed to produce specific outcomes. GLP-1 medications may cause side effects and are not appropriate for all patients. Discuss your medical history, current medications, and treatment goals with a licensed physician to determine the most appropriate approach for your individual situation.